NPPA Fixes Retail Price Of 20 New Drugs
New Delhi : The National Pharmaceutical Pricing Authority (NPPA) has announced retail price fixation of 20 new drugs based on the decision of its Authority meeting held on November 15,…
Govt Job: For Pharmacy & Life sciences professionals at CDRI
CSIR- Central Drug Research Institute (CSIR-CDRI), a premier drug research institute of India was inaugurated on 17th Feb 1951 by the then Prime Minister of India Pt. Jawaharlal Nehru with…
68 Cases Of Unapproved FDCs Licensed By SLAs Reported During 2017-21
New Delhi : A total of 68 cases in which the Fixed Dose Combinations (FDCs) considered as new drugs unapproved by the Central Drugs Standard Control Organisation (CDSCO) getting licensed…
Govt Job: For Pharmacists at Staff Selection Commission
The Government of HP, in exercise of the powers conferred under Article 162 read with proviso of Article 309 of the Constitution of India, constituted the HR Staff Selection Commission…
‘Absolutely fine,’ says Omicron-infected doctor
BENGALURU: The stigma of having his home sealed was more painful than the disease itself, says the 46-year-old doctor, one of the two patients in India infected with Omicron. He dispelled fears on…
Pharma Imports From China Grows 23% In April-September 2021
New Delhi : Imports of medicinal and pharmaceutical products from China to the country have seen a growth of 23 per cent during the first nine months of the current…
Govt Job: For Pharmacist at NPCIL under Dept of Atomic Energy
NPCIL, a premier Public Sector Enterprise under Department of Atomic Energy, Government of India having comprehensive capabilities in all facets of Nuclear Technology namely, Site Selection, Design, Construction, Commissioning, Operation,…
Indian Pharmaceutical Sector gears’ up for India’s Largest Pharma Expo!
Indian Pharma Expo is back and this year, it celebrates its 10thglorious year. The Indian Pharma Expo 2021 is scheduled to be held at 12A Pragati Maidan, New Delhi on…
Novavax says it could start making Omicron-specific vaccine in January
MARYLAND: Novavax Inc said on Thursday it could begin commercial manufacturing of a Covid-19 vaccine tailored for the Omicron coronavirus variant in January next year, while it tests whether or not its current vaccine…
Biocon gets USFDA nod for generic product
Biotechnology major Biocon on Thursday said its unit has received approval from the US health regulator to market a generic product. Biocon Pharma, a subsidiary of the company, has received approval from the US Food…
